A cross sectional study of clinical profile and evaluation of pulmonary hypertension in Chronic Obstructive Pulmonary Disease patients in a tertiary care hospital of Mangalore, India

Authors

  • Kshama S. Ramesh Department of Medicine, AJ Institute of Medical Sciences, Mangalore, Karnataka, India
  • Devdas B. Rai Department of Medicine, AJ Institute of Medical Sciences, Mangalore, Karnataka, India
  • Shayma Sheikh Abdulla Department of Medicine, AJ Institute of Medical Sciences, Mangalore, Karnataka, India
  • Jyothsna B. K. Department of Medicine, AJ Institute of Medical Sciences, Mangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20191136

Keywords:

COPD, Pulmonary hypertension, Non-invasive methods

Abstract

Background: The objectives was to study the clinical profile of COPD patients and to evaluate pulmonary hypertension in COPD patients by non-invasive methods.

Methods: A prospective observational study of patients who satisfy all inclusion and exclusion criteria in OPD or admitted in medical wards of AJIMS Mangalore. The study was conducted from October 2017 to October 2018 with the sample size of 90 subjects

Results: Out of 90 subjects 53 (58.8%) of them had pulmonary hypertension. Among the subjects who had pulmonary hypertension 29 (54.72%) of them had moderate pulmonary hypertension, 17 (32.08%) of them had severe pulmonary hypertension and 7 (13.20%) of them had mild pulmonary hypertension. Mean age among the subjects who had pulmonary hypertension was 64.24+7.62yrs and mean age among the subjects who didn’t had pulmonary hypertension was 51.87+8.97yrs. There was a statistically significant difference found between mean age and pulmonary hypertension. Mean duration of diseases among the subjects who had pulmonary hypertension was 8.13+1.74yrs and Mean duration of diseases among the subjects who didn’t had pulmonary hypertension was 5.36+1.98yrs. There was a statistically significant difference found between mean duration of disease and pulmonary hypertension.

Conclusions: Due to high prevalence of pulmonary hypertension we suggest screening for the all COPD patients for cardiac complications. This will help in identifying the individual who requires close monitoring and also in reducing the mortality.

References

GOLD. Guidelines, 2018. Available at: www.goldcopd.com.

Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397-412.

Petty TL. The history of COPD. Int J COPD. 2006;1(1):3-14.

Wrobel JP, Thompson BR, Williams TJ. Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic review. J Heart Lung Transplant. 2012;31:557-64.

Migueres M. Pulsed Doppler echocardiography in diagnosis of pulmonary hypertension in COPD. CHEST. 1990;98:280-5.

Mohapatra PR, Janmeja AK. Factors associated with hospital admission in patients with acute exacerbation of COPD. CHEST. 2011;52:203-6.

Goel S, Gupta BP, Kashyap S, Bhardwaj AK. Epidemiological aspects of chronic bronchitis in Shimla hills. Ind J Chest Dis All Sci. 2007;49(3):143.

Mahesh PA, Jayaraj BS, Prahalad T. Validation of a structured questionnaire for COPD and prevalence of COPD in rural area of Mysore; a pilot study. Lung India. 2009 Jul-Sep;26(3).

Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor’s diagnosis, symptoms, age, gender, and smoking habits. Respiration. 2005;72(5):471-9.

Higham MA. Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. European Respiratory J. 2001;17:350-5.

Gupta NK. Echocardiographic evaluation of heart in COPD patient and its correlation with severity of disease. Lung India. 2011 Apr-Jun;28(2):105-9.

Downloads

Published

2019-03-25

Issue

Section

Original Research Articles